CAS 1456889-80-7

Formule : C20H22N4O3

InChI : InChI=1S/C20H22N4O3/c1-4-27-19(25)10-12-24(18-7-5-6-11-21-18)20(26)15-8-9-17-16(13-15)22-14(2)23(17)3/h5-9,11,13H,4,10,12H2,1-3H3

Code InChI : WYUWBSPFQWDSIN-UHFFFAOYSA-N

SMILES : CCOC(=O)CCN(C1=CC=CC=N1)C(=O)C2=CC3=C(C=C2)N(C(=N3)C)C

Dabigatran Impurity 30

CAS : 1456889-80-7

Formule : C₂₀H₂₂N₄O₃

Couleur et forme : White To Off-White Solid

Masse moléculaire : 366.42

Ref: 4Z-D-5912

N-Nitroso Dabigatran Impurity 73 Trifluoroacetate

CAS : 1456889-80-7

Formule : C₂₇H₂₈N₈O₄·C₂HF₃O₂

Couleur et forme : White To Off-White Solid

Masse moléculaire : 528.57 114.02

Ref: 4Z-D-59127

Ethyl 3-(1,2-dimethyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate

CAS : 1456889-80-7

Degré de pureté : 98%

Ref: IN-DA00ANAB

ETHYL 3-(1,2-DIMETHYL-N-(PYRIDIN-2-YL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDO)PROPANOATE

CAS : 1456889-80-7

Degré de pureté : 98%

Masse moléculaire : 366.42099

Ref: 10-F827161

Dabigatran impurity E

Produit contrôlé

CAS : 1456889-80-7

Dabigatran impurity E is a potent kinase inhibitor that has shown promising results in the field of cancer research. It is an analog of a Chinese medicinal herb that has been traditionally used to treat various ailments, including cancer. Dabigatran impurity E has been shown to induce apoptosis in human cancer cells by inhibiting the activity of specific kinases involved in cell replication and survival. This compound also exhibits anticancer properties by inhibiting the growth and proliferation of tumor cells. Additionally, Dabigatran impurity E has been found in urine samples from cancer patients, suggesting its potential as a biomarker for cancer diagnosis and monitoring. Overall, this compound holds great promise as a novel therapeutic agent for the treatment of various types of cancers.

Formule : C₂₀H₂₂N₄O₃

Degré de pureté : Min. 95%

Masse moléculaire : 366.4 g/mol

Ref: 3D-GIC88980